Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Williams

Showing results (41-50 of 102) with videos related to

Pageof 11
Sort By:
Diabetes Care|October 27, 2004
Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?Michael P Stern, Ken Williams, Clicerio González-Villalpando, et al.
Circulation|October 29, 2003
Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS)Ken Williams, Allan D Sniderman, Naveed Sattar, et al.
Diabetes|January 29, 2005
Identification of individuals with insulin resistance using routine clinical measurementsSteven E Stern, Ken Williams, Eleuterio Ferrannini, et al.
JAMA|April 1, 2014
Proportion of US adults potentially affected by the 2014 hypertension guidelineAnn Marie Navar-Boggan, Michael J Pencina, Ken Williams, et al.
American Journal of Epidemiology|June 7, 2005
Re: "(Mis)use of factor analysis in the study of insulin resistance syndrome"Anthony J G Hanley, James B Meigs, Ken Williams, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 22, 2016
Estimating the Population Impact of Lp(a) Lowering on the Incidence of Myocardial Infarction and Aortic Stenosis-Brief ReportMehdi Afshar, Pia R Kamstrup, Ken Williams, et al.
American Journal of Hypertension|March 31, 2005
Lower hypertension risk in Mexico City than in San AntonioCarlos Lorenzo, Ken Williams, Clicerio Gonzalez-Villalpando, et al.
Frontiers in Public Health|October 6, 2025
"I am a Black man in Canada! I wish I could say differently!": exploring the impact of direct and indirect encounters with the police and welfare system on anxiety and depression among Black youth in Toronto, CanadaEyram Adzo Agbe, Ann Kwarteng, Tricia Tetteh, et al.
Circulation|August 7, 2002
Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitusSteven M Haffner, Andrew S Greenberg, Wayde M Weston, et al.
Circulation|March 6, 2016
Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular DiseaseGeorge Thanassoulis, Ken Williams, Kathleen Kimler Altobelli, et al.
Pageof 11

Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
Diabetes Care|October 27, 2004
Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?Michael P Stern, Ken Williams, Clicerio González-Villalpando, et al.
Circulation|October 29, 2003
Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS)Ken Williams, Allan D Sniderman, Naveed Sattar, et al.
Diabetes|January 29, 2005
Identification of individuals with insulin resistance using routine clinical measurementsSteven E Stern, Ken Williams, Eleuterio Ferrannini, et al.
JAMA|April 1, 2014
Proportion of US adults potentially affected by the 2014 hypertension guidelineAnn Marie Navar-Boggan, Michael J Pencina, Ken Williams, et al.
American Journal of Epidemiology|June 7, 2005
Re: "(Mis)use of factor analysis in the study of insulin resistance syndrome"Anthony J G Hanley, James B Meigs, Ken Williams, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 22, 2016
Estimating the Population Impact of Lp(a) Lowering on the Incidence of Myocardial Infarction and Aortic Stenosis-Brief ReportMehdi Afshar, Pia R Kamstrup, Ken Williams, et al.
American Journal of Hypertension|March 31, 2005
Lower hypertension risk in Mexico City than in San AntonioCarlos Lorenzo, Ken Williams, Clicerio Gonzalez-Villalpando, et al.
Frontiers in Public Health|October 6, 2025
"I am a Black man in Canada! I wish I could say differently!": exploring the impact of direct and indirect encounters with the police and welfare system on anxiety and depression among Black youth in Toronto, CanadaEyram Adzo Agbe, Ann Kwarteng, Tricia Tetteh, et al.
Circulation|August 7, 2002
Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitusSteven M Haffner, Andrew S Greenberg, Wayde M Weston, et al.
Circulation|March 6, 2016
Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular DiseaseGeorge Thanassoulis, Ken Williams, Kathleen Kimler Altobelli, et al.
Pageof 11